Decreased miR-124 expression has been reported to be an unfavorable independent prognostic factor for patients with breast cancer [29], whereas high IL-11 expression correlates with high histological grade and poor survival in breast cancer [44, 45]. The gene discussed is IL11; the disease is breast carcinoma.